Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Expanding clinical flow cytometry portfolio unveiled by Beckman Coulter at AACC

Expanding clinical flow cytometry portfolio unveiled by Beckman Coulter at AACC

Gene editing technology shines light on rare dyskeratosis congenita

Gene editing technology shines light on rare dyskeratosis congenita

New approach may improve translation of immunological research findings

New approach may improve translation of immunological research findings

Wayne State researchers receive $1.9 million NIH grant to better understand rare genetic disorders

Wayne State researchers receive $1.9 million NIH grant to better understand rare genetic disorders

New genomic research partnership promises to redefine and transform cancer treatment

New genomic research partnership promises to redefine and transform cancer treatment

New analysis compares emerging algorithms that look for cancer mutations

New analysis compares emerging algorithms that look for cancer mutations

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL)

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Researchers discover how new molecular scissors unzip and cleave DNA with high accuracy

Researchers discover how new molecular scissors unzip and cleave DNA with high accuracy

First systematic genomic analysis of patients with T-ALL may aid development of new therapies

First systematic genomic analysis of patients with T-ALL may aid development of new therapies

Timing of mutations can have effect on health and disease

Timing of mutations can have effect on health and disease

FDA authorizes marketing of test to aid in diagnoses of serious cancers

FDA authorizes marketing of test to aid in diagnoses of serious cancers

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

Researchers trace origins of AML relapse to rare therapy-resistant stem cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.